PCRX

PCRX Financing Cash Flow

-$376.18MTTM · USD

Period ending:

PCRX FY Cash from FinancingUSD
PCRX FY Cash from Financing2008-12-31: $40.17M2009-12-31: $21.04M2010-12-31: $50.71M2011-12-31: $87.16M2012-12-31: $63.61M2013-12-31: $89.17M2014-12-31: $118.88M2015-12-31: $10.70M2016-12-31: $7.26M2017-12-31: $224.16M2018-12-31: $8.95M2019-12-31: $3.67M2020-12-31: $222.30M2021-12-31: $380.69M2022-12-31: -$401.53M2023-12-31: -$183.03M2024-12-31: $17.36M2025-12-31: -$369.63M$380.69M-$401.53M
2008-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

PCRX financing cash flow history

Cash from issuing/repaying debt and equity. The available annual fiscal periods series contains 18 observations from Dec 31, 2008 to Dec 31, 2025.

Pacira Biosciences Inc Financing Cash Flow — Annual fiscal periods (USD)
Period endingFinancing Cash Flow (USD)
-369,627,000
17,363,000
-183,031,000
-401,528,000
380,694,000
222,304,000
3,670,000
8,954,000
224,162,000
7,261,000
10,699,000
118,875,000
89,165,000
63,610,000
87,158,000
50,705,000
21,038,000
40,173,000

Compare financing cash flow

All PCRX financial metrics · PCRX stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.